Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-18

FDA Approved: DANTROLENE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for Dantrolene, confirming approval of its generic product for the treatment of malignant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dantrolene (dantrolene)

Snippet

SUPPL AP for DANTROLENE (DANTROLENE)